CAI Buybacks
4 quarter-specific issuer repurchase-cash observations normalized from SEC filings, newest first. A filed zero remains visible; a missing filing fact is never converted into zero. This page shows rows 1–4; provenance stays internal.
| Issuer profile | Period end | Type | Reported cash |
|---|---|---|---|
| Caris Life Sciences, Inc. | 2026-03-31 | Reported repurchase cash | $0.00 |
| Caris Life Sciences, Inc. | 2025-12-31 | Reported repurchase cash | $91,000.00 |
| Caris Life Sciences, Inc. | 2025-03-31 | Reported repurchase cash | $22,000.00 |
| Caris Life Sciences, Inc. | 2024-12-31 | Reported repurchase cash | $0.00 |